세계의 심전도 센서 패치 시장 : 리드 유형별, 제품 유형별, 처방 유형별, 사용 모달리티별, 최종사용자별, 지역별 - 예측(-2032년)

The ECG sensor patches market is projected to reach USD 2.31 billion by 2032 from USD 1.05 billion in 2025, registering a CAGR of 12.0% during the forecast period. The key factors contributing to market growth include the rising integration of AI-powered arrhythmia detection algorithms within wearable ECG devices. Additionally, remote cardiac monitoring programs initiated by insurers in collaboration with digital health startups have specifically accelerated adoption in post-discharge cardiac patients. The availability of interoperable APIs enabling real-time ECG data transfer to cardiologists via EHRs enhances clinical workflow efficiency and remote diagnostics, boosting demand.

By usage modality, the wireless ECG sensor patch segment accounted for the largest market share in 2024.

In 2024, the wireless ECG sensor patch segment dominated usage modalities, primarily due to the rising deployment of Long Term Evolution Machine (LTE-M) and Narrowband Internet of Things (NB-IoT) based patch devices. These devices provide seamless data transmission without needing smartphones or external hubs. Due to their minimal interference and high patient compliance, they are also being prioritized in clinical trials for continuous cardiac rhythm monitoring in oncology patients receiving cardiotoxic chemotherapy. Additionally, FDA-cleared wireless models featuring automated, cloud-based ECG interpretation have improved remote patient monitoring in outpatient settings.

By end users, the home care settings segment is expected to grow at the highest CAGR during the forecast period.

By end user, the market is segmented into hospitals & clinics, ambulatory care centers, home care settings, urgent care centers, primary centers, and other end users. The home care settings segment is expected to grow at the highest CAGR during the forecast period. The rising approval of prescription-grade ECG patches for at-home cardiac rehabilitation monitoring and specific reimbursement expansions under remote therapeutic monitoring (RTM) codes are expected to fuel the market growth of this segment. Also, compact adhesive patch kits with pre-configured instructions explicitly tailored for older adults have drastically improved self-application rates, reducing the need for clinical intervention.

By region, North America is expected to witness the highest growth rate during the forecast period.

The key factors driving the market growth of North America include the unique convergence of payer-backed chronic care management programs and regulatory fast-tracking of Class II wearable cardiac devices. Specific CMS policies incentivizing 30-day remote ECG monitoring post-atrial fibrillation ablation have created a solid reimbursement ecosystem, particularly in the US. Collaborations between leading patch manufacturers and integrated delivery networks (IDNs) in Canada are expected to fuel the adoption of telecardiology. The adoption of this technology is further supported by Medicare plans that provide coverage for patch-based screening of silent atrial fibrillation (AF) in asymptomatic diabetic patients, promoting early intervention. These region-specific policies and healthcare infrastructure improvements significantly contribute to market expansion.

Breakdown of supply-side primary interviews:

• By Company Type: Tier 1 - 45%, Tier 2 - 20%, and Tier 3 - 35%
• By Designation: C-level - 35%, Director-level - 25%, and Others - 40%
• By Region: North America - 40%, Europe - 25%, Asia Pacific- 20%, Latin America - 10%, and the Middle East & Africa - 5%

Breakdown of demand-side primary interviews:

• By Company Type: Hospitals & Clinics - 38%, Home Care Settings - 25%, Ambulatory Surgery Centers - 20%, Urgent Care Settings - 12%, Primary Centers - 3%, and Other End Users - 2%.
• By Designation: Healthcare Professionals - 35%, Department Heads - 27%, Procurement Heads - 22%, and Other Designations- 16%
• By Region: North America - 40%, Europe - 25%, the Asia Pacific- 20%, Latin America - 10%, and the Middle East & Africa - 5%

Research Coverage

This report studies the ECG sensors market based on lead type, product type, prescription type, usage modality, end user, and region. The report also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Additionally, the report analyzes micro markets regarding their growth trends and forecasts the revenue of the market segments in five central regions and respective countries.

Reasons to Buy the Report

The report can help established and new entrants/smaller firms gauge the market's pulse, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.

This report provides insights into the following pointers:

• Analysis of key drivers (rising geriatric population, growing prevalence of cardiovascular diseases globally, technological advancements in wireless monitoring and wearable devices, increasing adoption of wearables, mHealth apps, and connected devices), restraints (high cost of advanced ecg sensor patch devices, data privacy and security concerns in digital health monitoring), opportunities (growing integration of al and predictive analytics, expansion of home healthcare and post-acute monitoring solutions, untapped emerging markets), and challenges (regulatory hurdles for product approval & market entry, accuracy & reliability concerns compared to traditional ECG devices) are expected to influence the growth of the ECG sensor patches market.
• Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and ECG sensor patches market product launches.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for several types of ECG procedures across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the ECG sensor patches market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the ECG sensor patches market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 STUDY ASSUMPTIONS
• 2.6 RISK ASSESSMENT
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ECG SENSOR PATCHES MARKET OVERVIEW
• 4.2 NORTH AMERICA: ECG SENSOR PATCHES MARKET OVERVIEW
• 4.3 ECG SENSOR PATCHES MARKET: REGIONAL MIX
• 4.4 ECG SENSOR PATCHES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.5 ECG SENSOR PATCHES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising geriatric population
    • 5.2.1.2 Growing prevalence of cardiovascular diseases globally
    • 5.2.1.3 Technological advancements in wireless monitoring and wearables
    • 5.2.1.4 Increasing adoption of wearables, mHealth apps, and connected devices
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of advanced ECG sensor patch devices
    • 5.2.2.2 Data privacy and security concerns in digital health monitoring
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing integration of AI and predictive analytics
    • 5.2.3.2 Expansion of home healthcare and post-acute monitoring solutions
    • 5.2.3.3 Untapped emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Regulatory hurdles for product approval and market entry
    • 5.2.4.2 Accuracy and reliability concerns compared to traditional ECG
• 5.3 INDUSTRY TRENDS
  • 5.3.1 AI-DRIVEN PREDICTIVE ANALYTICS AND REMOTE MONITORING EXPANSION
  • 5.3.2 RISING ADOPTION IN PREVENTIVE CARDIAC CARE AND HOME HEALTHCARE
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Bluetooth Low Energy (BLE)
    • 5.4.1.2 Cloud Computing
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Electronic Health Record (EHR) Integration
    • 5.4.2.2 mHealth Apps
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 Wearable Biosensors
• 5.5 PORTER'S FIVE FORCES ANALYSIS
  • 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5.2 BARGAINING POWER OF BUYERS
  • 5.5.3 BARGAINING POWER OF SUPPLIERS
  • 5.5.4 THREAT OF SUBSTITUTES
  • 5.5.5 THREAT OF NEW ENTRANTS
• 5.6 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.6.2 KEY BUYING CRITERIA
• 5.7 REGULATORY LANDSCAPE
  • 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
  • 5.7.2 REGULATORY FRAMEWORK
    • 5.7.2.1 North America
      • 5.7.2.1.1 US
      • 5.7.2.1.2 Canada
    • 5.7.2.2 Europe
      • 5.7.2.2.1 Germany
      • 5.7.2.2.2 European Union
      • 5.7.2.2.3 France
    • 5.7.2.3 Asia Pacific
      • 5.7.2.3.1 China
      • 5.7.2.3.2 Japan
      • 5.7.2.3.3 India
      • 5.7.2.3.4 Australia
    • 5.7.2.4 Latin America
      • 5.7.2.4.1 Brazil
      • 5.7.2.4.2 Mexico
    • 5.7.2.5 Middle East and Africa
      • 5.7.2.5.1 South Africa
      • 5.7.2.5.2 UAE
• 5.8 PATENT ANALYSIS
  • 5.8.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS, AND JURISDICTION FOR ECG SENSOR PATCHES MARKET, JANUARY 2015-APRIL 2025
  • 5.8.2 LIST OF MAJOR PATENTS, 2023-2024
• 5.9 TRADE ANALYSIS
  • 5.9.1 IMPORT DATA FOR HS CODE 901811
  • 5.9.2 EXPORT DATA FOR HS CODE 901811
• 5.10 REIMBURSEMENT ANALYSIS
• 5.11 KEY CONFERENCES & EVENTS, 2025-2026
• 5.12 PRICING ANALYSIS
  • 5.12.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.12.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.13 VALUE CHAIN ANALYSIS
• 5.14 SUPPLY CHAIN ANALYSIS
• 5.15 ECOSYSTEM ANALYSIS
• 5.16 UNMET NEEDS/END-USER EXPECTATIONS
• 5.17 IMPACT OF AI/GEN AI ON ECG SENSOR PATCHES MARKET
• 5.18 CASE STUDY ANALYSIS
  • 5.18.1 CASE STUDY 1: IRHYTHM TECHNOLOGIES' ZIO PATCH AND GUARD-AF STUDY
  • 5.18.2 CASE STUDY 2: BODYKOM-ENABLING MOBILE HEART MONITORING
• 5.19 ADJACENT MARKET ANALYSIS
• 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.21 INVESTMENT & FUNDING SCENARIO
• 5.22 IMPACT OF 2025 US TARIFFS-ECG SENSOR PATCHES MARKET
  • 5.22.1 INTRODUCTION
  • 5.22.2 KEY TARIFF RATES
  • 5.22.3 PRICE IMPACT ANALYSIS
  • 5.22.4 IMPACT ON COUNTRY/REGION
    • 5.22.4.1 US
    • 5.22.4.2 Europe
    • 5.22.4.3 Asia Pacific
  • 5.22.5 IMPACT ON END-USE INDUSTRIES
    • 5.22.5.1 Hospitals & clinics
    • 5.22.5.2 Ambulatory care centers & urgent care centers
    • 5.22.5.3 Home care settings
    • 5.22.5.4 Primary care centers & other end users (e.g., sport clinics and fitness centers)

6 ECG SENSOR PATCHES MARKET, BY LEAD TYPE

• 6.1 INTRODUCTION
• 6.2 SINGLE-LEAD ECG SENSOR PATCHES
  • 6.2.1 EXTENSIVE USE IN LONG-TERM CONTINUOUS MONITORING OF HIGH-RISK PATIENTS TO PROPEL DEMAND
• 6.3 2-LEAD ECG SENSOR PATCHES
  • 6.3.1 SUITABILITY FOR OUTPATIENT CARDIAC REHABILITATION PROGRAMS TO DRIVE ADOPTION
• 6.4 3-LEAD ECG SENSOR PATCHES
  • 6.4.1 RISING INTEGRATION INTO CLINICAL TRIALS AND REMOTE DIAGNOSTIC APPLICATIONS TO SUPPORT GROWTH
• 6.5 12-LEAD ECG SENSOR PATCHES
  • 6.5.1 APPLICATIONS IN EMERGENCY DIAGNOSTICS AND ACUTE CLINICAL ASSESSMENT TO DRIVE DEMAND
• 6.6 OTHER LEAD TYPES

7 ECG SENSOR PATCHES MARKET, BY PRODUCT TYPE

• 7.1 INTRODUCTION
• 7.2 DISPOSABLE ECG SENSOR PATCHES
  • 7.2.1 CONVENIENCE AND HYGIENE REQUIREMENTS IN SHORT-TERM MONITORING TO FUEL DEMAND
• 7.3 REUSABLE ECG SENSOR PATCHES
  • 7.3.1 DURABILITY AND LONG-TERM MONITORING NEEDS TO DRIVE MARKET

8 ECG SENSOR PATCHES MARKET, BY PRESCRIPTION TYPE

• 8.1 INTRODUCTION
• 8.2 PHYSICIAN-PRESCRIBED ECG SENSOR PATCHES
  • 8.2.1 PHYSICIAN-PRESCRIBED PATCHES TO HOLD LARGER SHARE DUE TO ADVANCED DIAGNOSTIC CAPABILITIES
• 8.3 OTC ECG SENSOR PATCHES
  • 8.3.1 HIGH GROWTH ATTRIBUTED TO RISING CONSUMER INTEREST IN PREVENTIVE CARDIAC WELLNESS

9 ECG SENSOR PATCHES MARKET, BY USAGE MODALITY

• 9.1 INTRODUCTION
• 9.2 WIRELESS ECG SENSOR PATCHES
  • 9.2.1 ROLE IN REMOTE MONITORING AND PATIENT COMFORT TO PROPEL DEMAND
• 9.3 WIRED/CONNECTED ECG SENSOR PATCHES
  • 9.3.1 WIRED/CONNECTED ECG SENSOR PATCHES TO MAINTAIN STRONG DEMAND DUE TO ACCURACY IN CLINICAL SETTINGS

10 ECG SENSOR PATCHES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HOSPITALS & CLINICS
  • 10.2.1 HIGH PATIENT VOLUME AND ADVANCED CARDIAC CARE TO DRIVE ECG PATCH ADOPTION
• 10.3 AMBULATORY CARE CENTERS
  • 10.3.1 EMPHASIS ON OUTPATIENT SERVICES AND RAPID DIAGNOSTICS TO BOOST ECG PATCH UTILIZATION
• 10.4 HOME CARE SETTINGS
  • 10.4.1 AGING POPULATION AND TELEHEALTH INTEGRATION TO PROPEL MARKET GROWTH
• 10.5 URGENT CARE CENTERS
  • 10.5.1 RAPID DIAGNOSTICS AND ACCESSIBILITY TO FUEL ECG PATCH INTEGRATION
• 10.6 PRIMARY HEALTH CENTERS
  • 10.6.1 FOUNDATIONAL ROLE IN CARDIAC SCREENING TO BOOST ECG PATCH UTILIZATION
• 10.7 OTHER END USERS

11 ECG SENSOR PATCHES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Technological advancements and chronic disease burden to drive market growth
  • 11.2.3 CANADA
    • 11.2.3.1 Digital health push and aging population to support market expansion
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Substantial healthcare investment and insurance coverage to drive market
  • 11.3.3 UK
    • 11.3.3.1 Aging population and digital health adoption to accelerate market growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Rapid uptake of ECG sensor patches with AI and home-based care to propel market
  • 11.3.5 ITALY
    • 11.3.5.1 AI regulations and rising healthcare demand to advance wearable cardiac monitoring
  • 11.3.6 SPAIN
    • 11.3.6.1 Growing elderly population and chronic disease prevalence to drive adoption
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 Robust public healthcare expansion to ensure China's market leadership
  • 11.4.3 JAPAN
    • 11.4.3.1 Aging population and universal health coverage drive adoption
  • 11.4.4 INDIA
    • 11.4.4.1 Government-led healthcare reforms to boost rapid market growth
  • 11.4.5 SOUTH KOREA
    • 11.4.5.1 Strong digital infrastructure and rising CVD burden to drive market
  • 11.4.6 AUSTRALIA
    • 11.4.6.1 Growing emphasis on healthcare for aging population and rising remote monitoring needs to drive market
  • 11.4.7 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 High CVD burden and favorable investment climate to fuel demand for ECG sensor patches
  • 11.5.3 MEXICO
    • 11.5.3.1 Rise in wearable tech adoption to support market growth
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST AND AFRICA
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Saudi Arabia
      • 11.6.2.1.1 Rising CVD burden and digital health ecosystem accelerate ECG sensor patch uptake
    • 11.6.2.2 UAE
      • 11.6.2.2.1 National preventive health campaigns to fuel adoption of ECG sensor patches
    • 11.6.2.3 Rest of GCC Countries
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS
• 12.3 REVENUE ANALYSIS (2020-2024)
• 12.4 MARKET SHARE ANALYSIS
  • 12.4.1 RANKING OF KEY MARKET PLAYERS
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Lead type footprint
    • 12.5.5.4 Product type footprint
    • 12.5.5.5 Prescription type footprint
    • 12.5.5.6 Usage modality type footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 DYNAMIC COMPANIES
  • 12.6.3 STARTING BLOCKS
  • 12.6.4 RESPONSIVE COMPANIES
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 12.6.5.1 Detailed list of key startups/SMEs
    • 12.6.5.2 Competitive benchmarking of key startups/SMEs
• 12.7 BRAND/PRODUCT COMPARISON
• 12.8 R&D EXPENDITURE OF KEY PLAYERS
• 12.9 COMPANY VALUATION & FINANCIAL METRICS
  • 12.9.1 FINANCIAL METRICS
  • 12.9.2 COMPANY VALUATION
• 12.10 COMPETITIVE SCENARIO
  • 12.10.1 PRODUCT APPROVALS/LAUNCHES
  • 12.10.2 DEALS
  • 12.10.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 BAXTER INTERNATIONAL INC.
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 MnM view
      • 13.1.1.3.1 Right to win
      • 13.1.1.3.2 Strategic choices
      • 13.1.1.3.3 Weaknesses and competitive threats
  • 13.1.2 IRHYTHM TECHNOLOGIES, INC.
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches & approvals
      • 13.1.2.3.2 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 KONINKLIJKE PHILIPS N.V.
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Expansions
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 GE HEALTHCARE TECHNOLOGIES INC.
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product approvals
      • 13.1.4.3.2 Deals
      • 13.1.4.3.3 Expansions
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Right to win
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses and competitive threats
  • 13.1.5 BOSTON SCIENTIFIC CORPORATION
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 MnM view
      • 13.1.5.3.1 Right to win
      • 13.1.5.3.2 Strategic choices
      • 13.1.5.3.3 Weaknesses and competitive threats
  • 13.1.6 BITTIUM CORPORATION
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches
      • 13.1.6.3.2 Deals
  • 13.1.7 BIOTRICITY INC.
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches & approvals
      • 13.1.7.3.2 Deals
  • 13.1.8 OSI SYSTEMS, INC.
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
  • 13.1.9 SMARTCARDIA INC.
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches & approvals
  • 13.1.10 LIFESIGNALS
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Product launches & approvals
      • 13.1.10.3.2 Deals
  • 13.1.11 VITALCONNECT
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Deals
  • 13.1.12 CARDIAC INSIGHT, INC.
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
  • 13.1.13 ALIVECOR, INC.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Product launches & approvals
  • 13.1.14 ISANSYS LIFECARE LTD.
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
  • 13.1.15 2M ENGINEERING
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products offered
• 13.2 OTHER PLAYERS
  • 13.2.1 QT MEDICAL INC.
  • 13.2.2 VIVALNK, INC.
  • 13.2.3 WELLYSIS
  • 13.2.4 MAWI
  • 13.2.5 VPATCH CARDIO PTY LTD
  • 13.2.6 SMARTMEDICS SP. Z O.O.
  • 13.2.7 ZYWIE HEALTH
  • 13.2.8 ATSENS CO., LTD.
  • 13.2.9 MEDIBIOSENSE
  • 13.2.10 MINTTIHEALTH

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS